Bill Maughan
Stock Analyst at Canaccord Genuity
(0.3)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
YMAB Y-mAbs Therapeutics | Downgrades: Hold | 26 9 | 8.52 | 0.94% | 3 | Aug 6, 2025 | |
KRYS Krystal Biotech | Initiates Coverage On: Buy | 190 | 137.58 | 38.1% | 1 | Jul 1, 2025 | |
CRSP CRISPR Therapeutics | Downgrades: Hold | 45 | 55.44 | -18.83% | 1 | Jun 27, 2025 | |
NKTX Nkarta | Maintains: Buy | 16 15 | 2 | 650% | 2 | May 10, 2024 | |
FATE Fate Therapeutics | Maintains: Buy | 11 9 | 0.94 | 857.45% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 63 67 | 31.9 | 110.03% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 91 106 | 25.48 | 316.01% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 24 | 0.49 | 4797.96% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 | 7.46 | 704.29% | 1 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 64.6 | -30.34% | 1 | Nov 2, 2023 |